Delaying latency to seizure by combinations of ketone supplements
AssigneeUniversity of South Florida
InventorsCsilla Ari D'Agostino, Dominic Paul D'Agostino, Jay B. Dean
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and methods for preventing central nervous system oxygen toxicity in a subject.
Claims20
A method of treating or preventing central nervous system oxygen toxicity (CNS-OT) in a subject in need thereof, the method comprising administering a composition comprising a therapeutically effective amount of a ketone ester and a medium chain triglyceride to the subject, wherein administering the composition comprises administering a daily amount of about 1 mg/kg to about 5 g/kg bodyweight of each of the ketone ester and MCT.
A method of treating or preventing seizures in a subject in need thereof, the method comprising administering a composition comprising a therapeutically effective amount of a ketone ester and a medium chain triglyceride to the subject,
- where in administering the composition comprises administering a daily amount of about 1 mg/kg to about 5 g/kg bodyweight of each of the ketone ester and MCT.
A method of treating or preventing epileptic seizures in a subject in need thereof, the method comprising administering a composition comprising a therapeutically effective amount of a ketone supplement comprising a ketone ester to the subject.
Dependencies are inferred from the claim text.